KREBSBIO Stock View

Krebs Biochemicals and Industries Ltd

KREBSBIO Stock View

(NSE)

Trade

₹ 64.25

1.29 | 1.99

Market Cap ₹( Cr.)
1,385.27

Proj. P/E (x)

Proj. P/BV (x)

Proj. ROE (%)

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)

Last Updated On.
17-Sep-2023

 

Copy Link

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry. It is also engaged in chemical synthesis, fermentation and enzymatic technologies. It manufactures various products, such as Androstenedione for use as steroid intermediate, and Lovastatin and Simvastatin for anti-cholesterol. It also undertakes contract manufacturing for pharmaceutical and multinational companies and developing products for sale in global markets. It has also products in the pilot or research and development stages, which include Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan and Phenylephrine. It has two manufacturing facilities, one is located at Regadichelaka, Nellore District, and another one located at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data